Tandem Diabetes Care (TNDM) Other Accumulated Expenses (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Other Accumulated Expenses for 14 consecutive years, with $81.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Accumulated Expenses fell 18.61% year-over-year to $81.4 million; the trailing twelve-month figure through Jun 2026 stood at $81.4 million (down 18.61% YoY), and the FY2025 full-year result was $75.2 million, up 52.57% from the prior year.
• Other Accumulated Expenses eased to $81.4 million in Q2 2026 per TNDM's latest filing, from $84.1 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $100.0 million in Q2 2025 and bottomed at $22.9 million in Q1 2022.
• Historically, Other Accumulated Expenses has averaged $50.5 million across 5 years, with a median of $34.1 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses surged 202.63% in 2025, then slipped 18.61% in 2026.
• Over 5 years, Other Accumulated Expenses stood at $29.3 million in 2022, then declined by 2.94% to $28.5 million in 2023, then jumped by 73.26% to $49.3 million in 2024, then jumped by 52.57% to $75.2 million in 2025, then climbed by 8.16% to $81.4 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $81.4 million, $84.1 million, and $75.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.